Home / Inspections / 1320030

FDA Inspection 1320030 — Shandong Lukang Shelile Pharmaceutical Co., Ltd.

Shandong Lukang Shelile Pharmaceutical Co., Ltd. — FEI 3001040579

The FDA completed an inspection of Shandong Lukang Shelile Pharmaceutical Co., Ltd. on April 30, 2026 in Jining. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 30, 2026
Fiscal Year
2026
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Jining (China)

Facility

Other inspections at this facility

  • 1274884 (VAI Fri May 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1080590 (NAI Fri Dec 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 953818 (NAI Fri Nov 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865966 (NAI Thu Dec 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 619046 (VAI Thu Jul 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources